Fundraising FoxHighbury Holdings — Full Portfolio
6 tracked investments · listed companies and verified rows first
Curve Health operates a telemedicine platform combined with data analytics and health information exchange that connects bedside providers with remote clinicians.
Digital HealthHealthtechMedical DevicesSaaSMiami, US
Timothy Peck(Director)inMatthew Michela(CEO & Board Member)inCharlene Frizzera(Director)Stephen Bruso(Director)
Co-investorsAlumni VenturesKapor CapitalLightspeed Venture PartnersRosecliff VenturesWestway CapitalCorrelation Ventures+6 more
Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.
HealthtechInsurTechUnited States, US
Todd Park(Founder)inEd Park(Founder)in
BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)inKathleen Sebelius(Director)
Co-investorsAndreessen HorowitzBronze InvestmentsCapital FactoryCox EnterprisesDns CapitalDreamers VC+30 more
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Founder)inRamsey Homsany(Founder)inRobert Andrade(Executive Officer, Director, Promoter)Maurice J. Costantini(Executive Officer, Director, Promoter)
Co-investorsAndreessen Horowitz+ND Capital8VCCarbon SiliconCatalio Capital Management, LPExplorer Investments+10 more
Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.
BiotechHealthtechCambridge, US
Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)
BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)
Co-investorsAlumni VenturesaMoonCatalio Capital Management, LPLightspeed Venture PartnersPolaris PartnersS32
ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
AI & Machine LearningBiotechDeep Tech
Josef von Rickenbach, PhD(Co-Founder)in
Co-investorsNew Enterprise Associates (NEA)Decheng CapitalMission Biocapital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Evermore
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.